The vaccine was granted emergency authorization by the Indian regulator on Sunday, but on the condition that Serum Institute doesn't export the shots to ensure that vulnerable populations in India are protected, Adar Poonawalla, the company's CEO, said in a phone interview with The Associated Press.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ncvzp1
via IFTTT
0 comments:
Post a Comment